Algouneh Arash, Caudle Michelle, Balci Tugce, Andrade Andrea, Penava Debbie, Saleh Maha
Schulich School of Medicine Western University London Ontario Canada.
Division of Clinical Genetics, Department of Pediatrics London Health Sciences Centre London Ontario Canada.
Clin Case Rep. 2022 Aug 8;10(8):e6202. doi: 10.1002/ccr3.6202. eCollection 2022 Aug.
Pathogenic variants in the and genes are associated with increased risk for breast and ovarian cancers. Concurrent mutations in both genes in the same individual are rare but pose specific challenges when identified, usually through multigene panel testing or infrequently from a genome-wide analysis, such as whole-exome sequencing (WES). We present a 15-year-old female patient with syndromic intellectual disability whose exome reanalysis identified secondary findings of pathogenic and variants, both inherited paternally. We discuss the significant challenges posed by this finding in genetic counseling and cancer risk management of an adolescent with nonverbal intellectual disability, as well as the impact on their family. This rare case highlights the potential increased diagnostic yield of whole exome sequencing reanalysis and the consequences of secondary medically actionable results in a pediatric patient.
BRCA1和BRCA2基因中的致病变异与乳腺癌和卵巢癌风险增加相关。同一患者同时存在这两个基因的突变很少见,但一旦通过多基因检测板检测发现,或者更罕见地通过全基因组分析(如全外显子组测序(WES))识别出来,就会带来特定挑战。我们报告了一名15岁患有综合征性智力障碍的女性患者,其外显子组重新分析发现了BRCA1和BRCA2致病变异的次要结果,两个变异均为父系遗传。我们讨论了这一发现给一名患有非言语性智力障碍青少年的遗传咨询和癌症风险管理带来的重大挑战,以及对其家庭的影响。这个罕见病例凸显了全外显子组测序重新分析可能提高诊断率,以及儿科患者中次要医学可干预结果的后果。